Asthma pathogenesis - Implications for novel therapies;Pathogenese des asthma bronchiale - Eröffnung neuer therapeutischer perspektiven

Medizinische Klinik

Volumn 96, Issue 1, 2001, Pages 15-25

  Beeh, Kai Michael ^a   Buhl, Roland ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Asthma; Immunology; Monoclonal antibodies; Pathogenesis; Therapy

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN E; INTERLEUKIN 5; INTERLEUKIN 5 ANTIBODY; INTERLEUKIN 8; MONOCLONAL ANTIBODY; OMALIZUMAB;

AIRWAY OBSTRUCTION; ASTHMA; CELL ACTIVATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE CONTROL; ENVIRONMENTAL FACTOR; HEREDITY; HUMAN; INFLAMMATORY DISEASE; MOLECULAR BIOLOGY; MORBIDITY; PARASYMPATHETIC NERVE CELL; PATHOGENESIS; PREVALENCE; REVIEW; SMOOTH MUSCLE FIBER; T LYMPHOCYTE;

EID: 0035863462     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/pl00002148     Document Type: Review

References (161)

1. Expression of B7 costimulatory molecules and CD1a antigen by alveolar macrophages in allergic bronchial asthma
2. Eosinophilic lung diseases
3. TH2 and "TH2-like" cells in allergy and asthma: Pharmacological perspectives
4. NK1 receptor antagonist CP-99, 994 inhibits cigarette smoke-induced neutrophil and eosinophil adhesion in rat tracheal venules
5. Neural mechanisms in asthma
6. Neurogenic inflammation and asthma
7. Elevation of total serum immunoglobulin E is associated with asthma in non-allergic individuals
8. Evidence for linkage of total serum IgE and bronchial hyperresponsiveness to chromosome 5q: A major regulatory locus important in asthma
9. Evidence for multiple genetic susceptibility loci for asthma
10. Family size, childhood infections and atopic diseases
11. The effect of nebulized recombinant interferon-gamma in asthmatic airways
12. Serum matrix metalloproteinase-9: Tissue inhibitor of metalloproteinase-1 ratio correlates with steroid responsiveness in moderate to severe asthma
13. Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response
14. Comparative degree and type of sensitization to common indoor and outdoor allergens in subjects with allergic rhinitis and/or asthma
15. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitis subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation
16. Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: Evidence for the human mast cell as a source of these cytokines
17. Cytokines in symptomatic asthma airways
18. Kinetics of eotaxin expression and its relationship to eosinophil accumulation and activation in bronchial biopsies and bronchoalveolar lavage (BAL) of asthmatic patients after allergen inhalation
19. The relationship of respiratory allergy, skin test reactivity, and serum IgE in a community population sample
20. Pathogenetische bedeutung von IgE-bindenden epitopen auf allergenen
21. Childhood asthma in four countries: A comparative survey
22. Association of asthma with serum IgE levels and skin-test reactivity to allergens
23. The role of respiratory viruses in asthma
24. A fatal cytokine-induced inflammatory response reveals a critical role for NK cells
25. Collagen deposition in large airways may not differentiate severe asthma from milder forms of the disease
26. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: Comparison and interaction with IL-1, IL-3, IL-6, and GM-CSF
27. The effect of intravenous administration of a chimeric anti-IgE antibody on serum IgE levels in atopic subjects: Efficacy, safety, and pharmakokinetics
28. Nasal beclomethason prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis
29. Effects of tachykinin NK1 receptor antagonists on vagal hyperreactivity and neuronal M2 muscarinic receptor function in antigen-challenged guinea pigs
30. Pulmonary neuronal M2 muscarinic receptor function in asthma and animal models of hyperreactivity
31. Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with ispirin-intolerant asthma
32. Central role of immunoglobulin (1g) E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: Inhibition by a non-anaphylactogenic anti-IgE antibody
33. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma
34. Leukotrienes are potent constrictors of human bronchi
35. Impaired airway function and wheezing in infancy: The influence of maternal smoking and a genetic predisposition to asthma
36. Allergen content in dust flora homes and schools in northern Norway in relation of sensitization and allergy symptoms in schoolchildren
37. Mechanisms of mucosal inflammation in the nose and lungs
38. Role of neutral endopeptidase and angiotensin converting enzyme in asthma
39. Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma. A 3-D morphometric study
40. Pretreatment with an antibody to interleukin-5 prevents loss of pulmonary M2 muscarinic receptor function in antigen-challenged guinea pigs
41. Airway hyperresponsiveness to acetycholine and to tachykinins after respiratory virus infection in the guinea pig
42. The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects
43. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation
44. Therapy of allergic pulmonary diseases with anti-IgE antibodies. A review
45. Respiratory syncitial virus infection: Its role in aeroallergen sensitization during the first two years in life
46. T cell receptor genetics, autoimmunity and asthma
47. Elevated levels of the eosinophil granule major basic protein in the sputum of patients with bronchial asthma
48. Parainfluenza virus infection damages inhibitory M2 muscarinic receptors on pulmonary parasympathetic nerves in the guinea pig
49. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia
50. Rapid increase in bone marrow eosinophil production and responses to eosinopoietic interleukins triggered by nasal allergen challenge
51. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice
52. Myofibroblast involvement in the allergen-induced late response in mild atopic asthma
53. Blood eosinophil number and activity in relation to lung function in patients with asthma and with eosinophilia
54. Endothelial leukocyte adhesion molecute-1 mediates antigen-induced airway inflammation and late-phase airway obstruction in monkeys
55. Selection of a human T helper type 1-like T cell subset by mycobacteria
56. The molecular biology of eosinophil granule proteins
57. Zur entstehung von atemwegsentzündung und atemwegshyperreaktivität: Einblicke aus dem asthma-maus-modell
58. A clinical and pathologic study of chronic sinusitis: The role of the eosinophil
59. CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines
60. Studies on normal range of serum IgE concentration
61. Eicosanoids and platelet-activating factor in allergic respiratory diseases
62. Therapeutic potential of anti-IgE antibodies
63. Airway smooth muscle cell culture: Application to studies of airway wall remodelling and phenotype plasticity in asthma
64. Interleukin-10 and transforming growth factor-beta promoter polymorphisms in allergies and asthma
65. Cigarette smoke-induced bronchoconstriction: Cholinergic mechanisms, tachykinins, and cyclooxygenase products
66. Mechanisms of enhanced prevalence of asthma and atopy in developed countries
67. Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation
68. Effects of a PAF antagonist, Y-24180, on bronchial hyperresponsiveness in patients with asthma
69. Prevalence of asthma and wheezing in public schoolchildren: Association with maternal smoking during pregnancy
70. IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: Evidence against "intrinsic" asthma being a distinct immunopathologic entity
71. High-affinity IgE receptor-bearing cells in bronchial biopsies from atopic and nonatopic asthma
72. Expression and release of interleukin-8 by human airway smooth muscle cells: Inhibition by Th-2 cytokines and corticosteroids
73. Human airway smooth muscle cells express and release RANTES in response to T helper 1 cytokines: Regulation by T helper 2 cytokines and corticosteroids
74. Leukocytes in asthma
75. T-lymphocytes, allergy and asthma
76. Release of granule proteins from eosinophils cultured with IL-5
77. Prediction and prevention of atopic allergy
78. Problems in defining normal limits for serum IgE
79. The role of eosinophils in asthma
80. Is there a place for intrinsic asthma as a distinct immunopathological entity?
81. Involvement of IL-5 in a murine model of allergic pulmonary inflammation: Prophylactic and therapeutic effect of an anti-IL-5 antibody
82. Endothelial leukocyte adhesion molecule-1 and intercellular adhesion molecule-1 mediate the adhesion of eosinophils to endothelial cells in vitro and are expressed by endothelium in allergic cutaneous inflammation in vivo
83. Negative regulation of airway responsiveness that is dependent on gammadelta T cells and independent of alphabeta T cells
84. Transfer of allergic airway responses with serum and lymphocytes from rats sensitized to dust mite
85. Dendritic cells are required for the development of chronic eosinophilic airway inflammation in response to inhaled antigen in sensitized mice
86. T and B cell immune response to a 55-kDa endothelial cell-derived antigen in severe asthma
87. Neurokinin A-LI release after antigen challenge in guinea-pig bronchial tubes: Influence of histamine and bradykinin
88. Association of being overweight with greater asthma symptoms in inner city black and hispanic children
89. Eotaxin increases the expression of CD11b/CD18 and adhesion properties in IL-5, but not fMLP-prestimulated human peripheral blood eosinophils
90. Cross-linking of CD23 antigen by its natural ligand (IgE) or by anti-CD23 antibody prevents B lymphocyte proliferation and differentiation
91. Down-regulation of FCERI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody
92. IgE receptors on human basophils. Relationship to serum IgE concentration
93. Rhinitis alone or rhinitis plus asthma: What makes the difference?
94. Approaches toward the genetic analysis of complex traits: Asthma and atopy
95. Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma
96. Molecular concepts of IgE-initiated inflammation in atopic and nonatopic asthma
97. Treatment of allergic asthma with monoclonal anti-IgE antibody
98. Therapeutic interference with interferon-gamma (IFN-gamma) and soluble IL-4 receptor (sIL-4R) in allergic diseases
99. Effect of neutral endopeptidase inhibitor on airway function and bronchial responsiveness in asthmatic subjects
100. A population-based study of bronchial asthma in adult twin pairs
101. The many faces of airway inflammation. Asthma and chronic obstructive pulmonary disease
102. Active anaphylaxis in IgE-deficient mice
103. Migration of eosinophils through basement membrane components in vitro: Role of matrix metalloproteinase-9
104. IgE-dependent expression of mRNA for IL-4 and IL-5 in human lung mast cells
105. Cytokine production by allergen (Der p I)-specific CD4+ T cell clones derived from a patient with severe atopic disease
106. Interleukin 4: Signalling mechanisms and control of T cell differentiation
107. Prevalence and severity of childhood asthma and allergic sensitization in seven climatic regions of New South Wales
108. Difficulties and dangers of vaccination strategies for asthma and other autoimmune disorders
109. Is there a dose-response relationship between exposure to indoor allergens and symptoms of asthma?
110. Genetic susceptibility to asthma-bronchial hyperresponsiveness coinherited with a major gene for atopy
111. Humanization of an antibody directed against IgE
112. A working classification of asthma
113. The role of matrix metalloproteases and their inhibitors in tumor invasion, metastasis and angiogenesis
114. Airway wall remodelling in asthma
115. The natural history of asthma in adults: The problem of irreversibility
116. T cells expressing specific Vβ elements regulate immunoglobulin E production and airways responsiveness in vivo
117. Activation of CD4+ T cells, increased Th2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma
118. Activated memory T helper cells in bronchoalveolar lavage fluid from patients with atopic asthma: Relation to asthma symptoms, lung function, and bronchial responsiveness
119. Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma
120. Subepithelial fibrosis in the bronchi of asthmatics
121. The R576 IL-4 receptor alpha allele correlates with asthma severity
122. Constitutive and allergen-induced expression of eotaxin mRNA in the guinea pig lung
123. Biosythesis of cysteinyl-leucotrienes in aspirin-intolerant asthma
124. Serum IgE levels predict human airway reactivity in vitro
125. Ozone-induced airway hyperresponsiveness and loss of neuronal M2 muscarinic receptor function
126. Aspirin and allergic diseases: A review
127. Ablation of eosinophil and IgE responses with anti-IL-5 or anti-IL-4 antibodies fails to affect immunity against Schistosoma mansoni in the mouse
128. The inverse association between tuberculin responses and atopic disorder
129. The effect of the orally active platelet-activating factor antagonist WEB 2086 in the treatment of asthma
130. Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. A prospective study
131. Cytokine (IL-10, IL-6) induction of tissue inhibitor of metalloproteinase 1 in primary human prostate tumor cell lines
132. Influence of parental smoking on respiratory symptoms during the first decade of life: The Tucson Children's Respiratory Study
133. Viral infections in atopic dermatitis
134. Immunomodulatory effects of IL-12 on allergic lung inflammation depend on timing of doses
135. The human IgE network
136. Bronchial reactivity and atopy in asthma discordant monozygotic twins
137. Functional screening of an asthma OTL in YAC transgenic mice
138. Aspirin-induced asthma: Advances in pathogenesis and management
139. Effects of IL-5, granulocyte/macrophage colony-stimulating factor (G M-CSF) and IL-3 on the survival of blood eosinophils in vitro
140. The incidence of respiratory tract infection in adults requiring hospitalization for asthma
141. Genes for asthma? An analysis of the European Community Respiratory Health Survey
142. Worldwide variation in prevalence of symptoms of asthma allergic rhinoconjunctivitis, and atopic eczema
143. The candidate region approach to the genetics of asthma and allergy
144. Genetic polymorphism of the angiotensin-converting enzyme (ACE) in asthmatic patients
145. A murine model of allergic rhinitis: Studies on the role of IgE in pathogenesis and analysis of the eosinophil influx elicited by allergen and eotaxin
146. Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs
147. Occupational asthma
148. Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis
149. Prevalence of asthma and atopy in two areas of West and East Germany
150. Increasing prevalence of hay fever and atopy among children in Leipzig, East Germany
151. Allergic and nonallergic asthmatics have distinct patterns of T-Cell activation and cytokine production in peripheral blood and bronchoalveolar lavage
152. T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma
153. IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner
154. Role of IgE in hyperresponsiveness induced by passive sensitization of human airways
155. Efficacy of monoclonal antibodies against adhesion molecules in animal models of asthma
156. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics
157. Empfehlungen zur asthma-therapie bei kindern und erwachsenen
158. Interleukin-12 as a target for modulation of the inflammatory response in asthma
159. Allergen challenge increases cell traffic between bone marrow and lung
160. Growth factors secreted by bronchial epithelial cells control myofibroblast proliferation: An in vitro co-culture model of airway remodelling in asthma